138 filings
Page 5 of 7
8-K/A
5rdhq u95x2
26 Oct 20
Submission of Matters to a Vote of Security Holders
4:39pm
8-K
thkv8vbe1jg 4elbh
5 Aug 20
Allogene Therapeutics Reports Second Quarter 2020 Financial Results
7:36am
8-K
l242 6cm163v9
11 Jun 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
njc902j1b99x4g
4 Jun 20
Allogene Therapeutics Announces Commencement of Public Offering of Common Stock
4:28pm
424B5
o14vcso3l86khug
3 Jun 20
Prospectus supplement for primary offering
4:14pm
424B5
mxt2z
1 Jun 20
Prospectus supplement for primary offering
6:38am
8-K
kvrf5eg
29 May 20
Other Events
8:08am
8-K
fkk902ryc0qmu1f8272
6 May 20
Allogene Therapeutics Reports First Quarter 2020 Financial Results
7:35am
DEFA14A
s4mawf6b
23 Apr 20
Additional proxy soliciting materials
4:45pm
8-K
dfndcgn
27 Mar 20
Other Events
8:17am
8-K
4aqtic
27 Feb 20
Allogene Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
7:30am
S-8
1vfd4
27 Feb 20
Registration of securities for employees
12:00am
8-K
3s4g5nyub1wlqx
20 Dec 19
Departure of Directors or Certain Officers
4:04pm
8-K
ke4079pm v45q7dz0n1o
5 Nov 19
Entry into a Material Definitive Agreement
4:39pm
S-3ASR
q0eigch3 w6
5 Nov 19
Automatic shelf registration
4:31pm